Medical/Pharmaceuticals

Menarini Silicon Biosystems launches new breakthrough DEPArray™ PLUS image-based cell sorter to isolate rare cells with single cell precision

DEPArray™ PLUS – the new automated and versatile platform to investigate pre-selected rare cell populations from various samples with 100% purity, now enhanced with 9 fluorescent channels and remarkably improved user experience BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., May 27, 2021 /PRNewswire/ ...

2021-05-27 15:00 1304

Love Never Stops, Joining hands to care NMOSD patients across Asia and saying "NO" to relapse

BEIJING, May 27, 2021 /PRNewswire/ -- There is such a group of patients, who are at the golden age of their lives and should have been energetic students in the ivory tower, ladies braving the wind and waves in the workplace, or warm wives expecting at home … Their lives were full of hopes and dr...

2021-05-27 14:18 2196

Neteera makes annual CNBC Disruptor 50 list second year running

JERUSALEM, May 27, 2021 /PRNewswire/ -- Neteera , global leader in contactless vital signs sensing, has been named for the second year running to theCNBC Disruptor 50 , an annual list of private venture-backed companies transforming...

2021-05-27 09:00 1907

Gannex Received China IND Approval of Its FXR Agonist ASC42 for NASH Indication

SHANGHAI, May 27, 2021 /PRNewswire/ -- Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672), fully dedicated to the R&D and commercialization of new drugs in the field of non-alcoholic steatohepatitis (NASH), today announces that China National Medical Products Administration (NMP...

2021-05-27 08:30 2874

WuXi Biologics and OncoC4 Establish Exclusive CDMO Partnership

SHANGHAI and ROCKVILLE, Md., May 27, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, and OncoC4, Inc., a privately-held, clinical-stage biopharmaceutical company, today announced that the companies have entered ...

2021-05-27 08:30 5208

Advanced Micro- and Nanofluidics to Revolutionize the Point-of-care Diagnostic Industry

With the COVID-19 outbreak rapidly decentralizing healthcare diagnostics, the use of microfluidics-based point-of-care diagnostic devices can provide higher accuracy, finds Frost & Sullivan SANTA CLARA, Calif., May 27, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis, Advanced Micro- and ...

2021-05-27 02:59 1396

Inteleos Announces MedGlobal and Global Ultrasound Institute as MissionPOCUS Selection for 2021

ROCKVILLE, Md., May 26, 2021 /PRNewswire/ -- The Point-of-Care Ultrasound (POCUS) Certification Academy under Inteleos announced a pilot project with MedGlobal and the Global Ultrasound Institute as the selection of their MissionPOCUS™ project for 2021. As the fourth MissionPOCUS project since th...

2021-05-26 23:36 1459

Boan Biotech Grants AstraZeneca Exclusive Rights to Promote Boyounuo(R) (Bevacizumab Injection) in Specific County Markets of China

SHANGHAI, May 26, 2021 /PRNewswire/ -- Luye Pharma Group announced today that its holding subsidiary, Boan Biotech, has signed an agreement with AstraZeneca China regarding the promotion rights to the anticancer drugBoyounuo®  (Bevacizumab Injection), under which the former will grant to the latte...

2021-05-26 23:03 19459

Merck Accelerates Scale Up of Lipids to Meet Covid-19 Demand

- Introduces new synthetic cholesterol product nine months ahead of schedule - Offers high purity, scalability, and consistent quality - One of a few companies that produces lipids in quantities needed to meet demand for mRNA therapeutics, including Pfizer-BioNTech Covid-19 Vaccine   DARMSTADT,...

2021-05-26 20:00 2251

RedHill Biopharma Receives Allowances for U.S. Patent Applications Covering Opaganib and RHB-107 for COVID-19

The two patents protect opaganib and RHB-107 for the treatment of COVID-19 until at least 2041 once granted Enrollment in opaganib's global Phase 2/3 study in hospitalized patients with severe COVID-19 is almost 100% complete RHB-107's ongoing Phase 2/3 study is enrolling U.S. non-hospitalized p...

2021-05-26 19:12 9166

IntoCare Medical Completes Up to 100 million RMB Round D Financing, Doubling Down on Powered Stapling Industry

SUZHOU, China, May 26, 2021 /PRNewswire/ -- IntoCare Medical Technology (Suzhou) Co., Ltd. (hereinafter referred to as "IntoCare"), a global pioneer in Powered Surgical Staplers, today announced the completion of up to100 million RMB round D financing. Qiming Venture Partners led the investment w...

2021-05-26 12:20 2943

Texas Cardiac Arrhythmia Institute leader participates in clinical trial for catheter that may reduce complication risk during cardiac ablation

AUSTIN, Texas, May 26, 2021 /PRNewswire/ -- The leader of the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center participated in a clinical study to evaluate the safety and effectiveness of a new lattice sphere catheter designed to optimize procedural efficiency and efficacy ...

2021-05-26 10:13 2367

Sinovant Sciences and Nabriva Therapeutics Announce Positive Topline Results from Phase 3 Trial of Lefamulin in Chinese Adults with Community Acquired Bacterial Pneumonia (CABP)

- Lefamulin was shown to be non-inferior to moxifloxacin, with 76.8% of lefamulin-treated patients meeting the efficacy endpoint of Investigator Assessment of Clinical Response (IACR) at Test of Cure (TOC), compared to 71.4% of patients treated with moxifloxacin - Lefamulin was generally safe an...

2021-05-26 05:00 2393

Nanoform and Celanese Explore Ways to Enhance Drug Delivery

HELSINKI, May 25, 2021 /PRNewswire/ -- Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Celanese Corporation (NYSE: CE), a global specialty materials company, today announced plans to explore the synergies between their respective technologies in the field of nanop...

2021-05-25 21:45 1817

OptraSCAN Announces CytoSiA - A Complete Digital Solution For Scanning And Analysis Of Cytology Slides At Affordable Pricing

- OptraSCAN's Intelligent Tool CytoSiA – To Advance Cytology Screening Through Unmatched Image Quality And Artificial Intelligence Based Image Analysis Solution SAN JOSE, Calif. and PUNE, India, May 25, 2021 /PRNewswire/ -- OptraSCAN ®, the leading On-Demand Digital P...

2021-05-25 21:27 2745

Spinal Stabilization Technologies Ltd Earns CE Mark, FDA "Breakthrough Designation" For PerQdisc Nucleus Replacement System For Degenerative Disc Disease

KILKENNY, Ireland, May 25, 2021 /PRNewswire/ -- Spinal Stabilization Technologies, Ltd. (SST),Kilkenny, Ireland announced today that it has earned the CE Mark and the FDA's "breakthrough designation" for its PerQdisc™ Nucleus Replacement System. PerQdisc is the only commercially available lumbar...

2021-05-25 21:09 2143

Ajinomoto Bio-Pharma Services Expands Fill Finish Capacity with New Multi-Purpose Fill Suite

SAN DIEGO, May 25, 2021 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, today announced it will soon open a high speed multi-purpose fill finish line in its state-of-the-art commercial manuf...

2021-05-25 20:05 1431

Boston Scientific Completes CE Mark for EXALT™ Model B Single-Use Bronchoscope

Company to begin limited market release in Europe in June MARLBOROUGH, Mass., May 25, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has completed CE Mark for the EXALT™ Model B Single-Use Bronchoscope, a single-use device designed for bedside procedures in the...

2021-05-25 18:50 2853

IVF Life the first clinic group in Europe to use Artificial Intelligence to non-invasively assess the genetic integrity of embryos

ADELAIDE, Australia, May 25, 2021 /PRNewswire/ -- IVF Life Group, a leading group of IVF clinics acrossSpain, UK, and Germany, will be among the first in Europe to use Artificial Intelligence (AI) to non-invasively assess embryos to determine their genetic integrity. The AI product Life Whisperer...

2021-05-25 17:15 1530

Seegene reports solid results in the first quarter of 2021 with KRW 351.8 billion

* SEEGENE POSTS KRW 193.9 BIL. IN OPERATING PROFIT, UP 388% ON-YEAR * OPERATING PROFIT RATIO AT 55%, DESPITE CONSTANT INVESTMENT IN R&D AND EMPLOYEES SEOUL, South Korea, May 25, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a molecular diagnostics company reported its financial results for th...

2021-05-25 15:33 11859
1 ... 282283284285286287288 ... 397